Kang DE[au] - Search Results

Year	Number of Results
1993	1
1997	1
1998	2
1999	1
2000	2
2001	2
2002	1
2004	1
2005	4
2006	1
2007	5
2008	2
2009	3
2010	2
2011	3
2012	4
2013	9
2014	5
2015	5
2016	3
2017	10
2018	6
2019	7
2020	6
2021	3

1

Cofilin, a Master Node Regulating Cytoskeletal Pathogenesis in Alzheimer's Disease.

Kang DE, Woo JA. Kang DE, et al. J Alzheimers Dis. 2019;72(s1):S131-S144. doi: 10.3233/JAD-190585. J Alzheimers Dis. 2019. PMID: 31594228 Free PMC article. Review.

2

Network pharmacology-based analysis of Chinese herbal Naodesheng formula for application to Alzheimer's disease.

Pang XC, Kang D, Fang JS, Zhao Y, Xu LJ, Lian WW, Liu AL, DU GH. Pang XC, et al. Among authors: kang d. Chin J Nat Med. 2018 Jan;16(1):53-62. doi: 10.1016/S1875-5364(18)30029-3. Chin J Nat Med. 2018. PMID: 29425590

3

CHCHD10-regulated OPA1-mitofilin complex mediates TDP-43-induced mitochondrial phenotypes associated with frontotemporal dementia.

Liu T, Woo JA, Bukhari MZ, LePochat P, Chacko A, Selenica MB, Yan Y, Kotsiviras P, Buosi SC, Zhao X, Kang DE. Liu T, et al. Among authors: kang de. FASEB J. 2020 Jun;34(6):8493-8509. doi: 10.1096/fj.201903133RR. Epub 2020 May 5. FASEB J. 2020. PMID: 32369233

4

β-Arrestin2 oligomers impair the clearance of pathological tau and increase tau aggregates.

Woo JA, Liu T, Fang CC, Castaño MA, Kee T, Yrigoin K, Yan Y, Cazzaro S, Matlack J, Wang X, Zhao X, Kang DE, Liggett SB. Woo JA, et al. Among authors: kang de. Proc Natl Acad Sci U S A. 2020 Mar 3;117(9):5006-5015. doi: 10.1073/pnas.1917194117. Epub 2020 Feb 18. Proc Natl Acad Sci U S A. 2020. PMID: 32071246 Free PMC article.

5

Corticosteroid plus β₂-agonist in a single inhaler as reliever therapy in intermittent and mild asthma: a proof-of-concept systematic review and meta-analysis.

Wang G, Zhang X, Zhang HP, Wang L, Kang Y, Barnes PJ, Wang G. Wang G, et al. Respir Res. 2017 Dec 6;18(1):203. doi: 10.1186/s12931-017-0687-6. Respir Res. 2017. PMID: 29207999 Free PMC article. Review.

6

Activated cofilin exacerbates tau pathology by impairing tau-mediated microtubule dynamics.

Woo JA, Liu T, Fang CC, Cazzaro S, Kee T, LePochat P, Yrigoin K, Penn C, Zhao X, Wang X, Liggett SB, Kang DE. Woo JA, et al. Among authors: kang de. Commun Biol. 2019 Mar 22;2:112. doi: 10.1038/s42003-019-0359-9. eCollection 2019. Commun Biol. 2019. PMID: 30911686 Free PMC article.

7

Members of FOX family could be drug targets of cancers.

Wang J, Li W, Zhao Y, Kang D, Fu W, Zheng X, Pang X, Du G. Wang J, et al. Among authors: kang d. Pharmacol Ther. 2018 Jan;181:183-196. doi: 10.1016/j.pharmthera.2017.08.003. Epub 2017 Aug 19. Pharmacol Ther. 2018. PMID: 28830838 Review.

8

Dual role of cofilin in APP trafficking and amyloid-β clearance.

Liu T, Woo JA, Yan Y, LePochat P, Bukhari MZ, Kang DE. Liu T, et al. Among authors: kang de. FASEB J. 2019 Dec;33(12):14234-14247. doi: 10.1096/fj.201901268R. Epub 2019 Oct 24. FASEB J. 2019. PMID: 31646885 Free PMC article.

9

Early disruption of nerve mitochondrial and myelin lipid homeostasis in obesity-induced diabetes.

Palavicini JP, Chen J, Wang C, Wang J, Qin C, Baeuerle E, Wang X, Woo JA, Kang DE, Musi N, Dupree JL, Han X. Palavicini JP, et al. Among authors: kang de. JCI Insight. 2020 Nov 5;5(21):e137286. doi: 10.1172/jci.insight.137286. JCI Insight. 2020. PMID: 33148881 Free PMC article.

10

The sphingosine kinase-1/sphingosine-1-phosphate axis in cancer: Potential target for anticancer therapy.

Zheng X, Li W, Ren L, Liu J, Pang X, Chen X, Kang D, Wang J, Du G. Zheng X, et al. Among authors: kang d. Pharmacol Ther. 2019 Mar;195:85-99. doi: 10.1016/j.pharmthera.2018.10.011. Epub 2018 Oct 19. Pharmacol Ther. 2019. PMID: 30347210 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results